drug · small molecule
patient view →lumacaftor
Phase 2updated 2mo agoby Qanatpharma AG🔗 ChEMBL
Phase 2community read0 votes
Small molecule drug with a maximum clinical stage of Approval (across all indications), with an approval for cystic fibrosis and acute lung injury and 3 investigational indications.
targets
Cystic fibrosis transmembrane conductance regulator
all catalysts(0)
nothing on the calendar yet
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that